AI-based Model CRM to Evaluate the Responses of Breast Cancer Patients to CDK4/6 Inhibitors-Based Therapies and Simulate Real-World Clinical Trials https://www.medrxiv.org/content/10.1101/2023.05.15.23289976
AI-based Model CRM to Evaluate the Responses of Breast Cancer Patients to CDK4/6 Inhibitors-Based Therapies and Simulate Real-World Clinical Trials https://www.medrxiv.org/content/10.1101/2023.05.15.23289976